CEN/TC 140
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 31365 | LVS EN ISO 19001:2013 | In vitro diagnostic medical devices - Information supplied by the manufacturer with in vitro diagnostic reagents for staining in biology (ISO 19001:2013) | Standarts spēkā |
| 75465 | LVS CEN/TS 17981-2:2023 | In vitro diagnostic Next Generation Sequencing (NGS) workflows - Part 2: Human RNA examination | Standarts spēkā |
| 70929 | LVS EN ISO 18113-1:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 1: Terms, definitions, and general requirements (ISO 18113-1:2022) | Standarts spēkā |
| 61694 | LVS EN ISO 20184-1:2019 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for frozen tissue - Part 1: Isolated RNA (ISO 20184-1:2018) | Standarts spēkā |
| 60817 | LVS EN ISO 23640:2015 | In vitro diagnostic medical devices - Evaluation of stability of in vitro diagnostic reagents (ISO 23640:2011) | Standarts spēkā |
| 5109 | LVS EN 13532:2003 | General requirements for in vitro diagnostic medical devices for self-testing | Standarts spēkā |
| 5107 | LVS EN 13641:2003 | Elimination or reduction of risk of infection related to in vitro diagnostic reagents | Standarts spēkā |
| 70931 | LVS EN ISO 18113-3:2024 | In vitro diagnostic medical devices - Information supplied by the manufacturer (labelling) - Part 3: In vitro diagnostic instruments for professional use (ISO 18113-3:2022) | Standarts spēkā |
| 70517 | LVS EN ISO 20184-3:2021 | Molecular in vitro diagnostic examinations - Specifications for pre-examination processes for frozen tissue - Part 3: Isolated DNA (ISO 20184-3:2021) | Standarts spēkā |
| 5111 | LVS EN 14136:2004 | Use of external quality assessment schemes in the assessment of the performance of in vitro diagnostic examination procedures | Standarts spēkā |
Displaying 41-50 of 275 results.